AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « subjects »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
subjective < subjects < subklassen  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]
Ident.Authors (with country if any)Title
000048 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Yosuke Nishioka [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
000283 (2011) A. Arman [Turquie] ; A. Coker [Turquie] ; O. Sarioz [Turquie] ; N. Inanc [Turquie] ; H. Direskeneli [Turquie]Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population
000462 (2013) Reinhard P. T. Rychlik [Allemagne]Target patient population: how does the regulatory and reimbursement view differ? Insights from the German IQWiG
000654 (2013) U. Klein [Suisse] ; E. Liang [Suisse] ; B. Vogel [Suisse] ; F. Kolbinger [Suisse] ; G. Bruin [Suisse] ; P. Lloyd [Suisse]SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients
000699 (2012) Young Ho Lee [Corée du Sud] ; Sang-Cheol Bae [Corée du Sud] ; Sung Jae Choi [Corée du Sud] ; Jong Dae Ji [Corée du Sud] ; Gwan Gyu Song [Corée du Sud]The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis
000727 (2013) G. Burmester [Allemagne] ; T. Takeuchi [Japon] ; O. Barbarash [Russie] ; G. Ranganna [Royaume-Uni] ; D. Close [Royaume-Uni] ; A. Godwood [Royaume-Uni] ; D. Saurigny [Royaume-Uni]FRI0232 Consistent efficacy and safety outcomes between european and japanese subjects with rheumatoid arthritis following treatment with mavrilimumab in the phase 2 earth study
000743 (2013) A. Brodsky [États-Unis] ; E. Diri [États-Unis] ; I. Garcia-Delatorre [Mexique] ; D. F. Alvarez ; C. Bencan [États-Unis] ; J. Bukowski [États-Unis] ; C. Zang [États-Unis]FRI0244 Clinical efficacy of 2 dosing regimens of tru-015, a b cell-depleting agent, in subjects with active seropositive rheumatoid arthritis compared with placebo on a stable background of methotrexate
000825 (2013) N. Al Kotbi [Pays-Bas] ; L. Jensen ; L. B. Graff [Danemark]FRI0196 NNC0109-0012 (anti-IL-20 MAB), well tolerated in healthy subjects and patients with rheumatoid arthritis
000991 (2013) G. A. Karpouzas ; J. Malpeso [États-Unis] ; T.-Y. Choi [États-Unis] ; S. Munoz ; M. Budoff [États-Unis]THU0057 Differential impact of traditional cardiac risk factors on coronary plaque prevalence in coronary artery disease (CAD)-naïve subjects with rheumatoid arthritis compared to controls
000998 (2013) C.-Y. Wu [États-Unis] ; X. Chen [États-Unis] ; H. Lu [États-Unis] ; E. Esfandiari ; F. Magrini ; A. Godwood [Royaume-Uni] ; P. Ryan ; C. Kane [États-Unis] ; L. Roskos [États-Unis] ; B. Wang [États-Unis]FRI0182 Pharmacokinetics and immunogenicity of mavrilimumab administered subcutaneously in subjects with rheumatoid arthritis
000A39 (2012) Eugeniusz Hrycek [Pologne] ; Andrzej Franek [Pologne] ; Edward Błaszczak [Pologne] ; Justyna Dworak [Pologne] ; Antoni Hrycek [Pologne]Serum levels of selected chemokines in systemic lupus erythematosus patients
000A46 (2013) Gleb Slobodin [Israël] ; Lisa Kaly [Israël] ; Regina Peri [Israël] ; Aharon Kessel [Israël] ; Itzhak Rosner [Israël] ; Elias Toubi [Israël] ; Doron Rimar [Israël] ; Nina Boulman [Israël] ; Michael Rozenbaum [Israël] ; Majed Odeh [Israël]Higher Expression of Latency-Associated Peptide on the Surface of Peripheral Blood Monocytes in Patients with Rheumatoid Arthritis may be Protective Against Articular Erosions
000A57 (2011) Mara Anaís Llamas-Covarrubias [Mexique] ; Yeminia Valle [Mexique] ; Rosa Elena Navarro-Hernández [Mexique] ; Iris Paola Guzmán-Guzmán [Mexique] ; María Guadalupe Ramírez-Due As [Mexique] ; Héctor Rangel-Villalobos [Mexique] ; Ciro Estrada-Chávez [Mexique] ; José Francisco Mu Oz-Valle [Mexique]Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course
000C77 (2008) Ingo H. Tarner [Allemagne] ; Ulf Müller-Ladner [Allemagne] ; Christine Uhlemann [Allemagne] ; Uwe Lange [Allemagne]The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis
000D26 (2013) A. Matucci [Italie] ; S. Pratesi [Italie] ; G. Petroni [Italie] ; F. Nencini [Italie] ; G. Virgili [Italie] ; M. Milla [Italie] ; E. Maggi [Italie] ; A. Vultaggio [Italie]Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab
000E28 (2011) Brahim Selmaoui [France] ; Jacques Lambrozo [France] ; Linda Sackett-Lundeen [États-Unis] ; Erhard Haus [États-Unis] ; Yvan Touitou [France]Acute Exposure to 50-Hz Magnetic Fields Increases Interleukin-6 in Young Healthy Men
000E63 (2011) G. Pongratz [Allemagne] ; R. H. Straub [Allemagne]Rheuma, Jetlag und die innere Uhr
000F30 (2012) Thomas Karonitsch [Autriche] ; Karolina Von Dalwigk [Autriche] ; Carl W. Steiner [Autriche] ; Stephan Blüml [Autriche] ; Günter Steiner [Autriche] ; Hans P. Kiener [Autriche] ; Josef S. Smolen [Autriche] ; Martin Aringer [Allemagne]Interferon signals and monocytic sensitization of the interferon‐γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis
000F53 (2015) Juliette Coat [France] ; Julien Demoersman [France] ; Sébastien Beuzit [France] ; Divi Cornec [France] ; Valérie Devauchelle-Pensec [France] ; Alain Saraux [France] ; Jacques-Olivier Pers [France]Anti‐B lymphocyte immunotherapy is associated with improvement of periodontal status in subjects with rheumatoid arthritis
000F89 (2013) R. P. Poggenborg [Danemark] ; I. Eshed [Israël] ; S. J. Pedersen ; I. J. S Rensen [Danemark] ; O. R. Madsen ; J. M Ller [Danemark] ; M. Stergaard [Danemark]OP0165 Whole-body MRI for assessment of enthesitis in psoriatic arthritis, axial spondyloarthritis and healthy subjects – a comparison with 7 clinical enthesitis indices
001211 (2010) Shunsuke Mori [Japon] ; Jun Hirose [Japon] ; Kensuke Yonemura [Japon]Contribution of HLA-DRB1*04 alleles and anti-cyclic citrullinated antibodies to development of resistance to disease-modifying antirheumatic drugs in early rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "subjects" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "subjects" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    subjects
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021